Stellantis Plans to Sell Four European Factories

Stellantis' plan to sell four factories in Europe increases the short-term risk of reducing the company's production capacity and revenue potential. This news is likely to heighten investor risk perception and could keep the price under downward pressure. The RSI falling below 30 indicates oversold territory, which may offer a short-term recovery opportunity. However, the price remaining below the 20- and 50-day moving averages supports the current downtrend. The price is expected to continue with a slight decline over the next 1-3 days.

GM stock is in a technically neutral zone. The RSI at 58.8 signals neither overbought nor oversold conditions. Although the MACD line is above the signal line, it has not yet entered positive territory, indicating a weak bullish signal. The price is above the 20-day moving average but trading near the 50-day moving average. While the news of Stellantis' plant sale does not directly affect GM, it points to a contraction in the European automotive sector, which could weaken sector sentiment. No clear direction is expected in the short term.

Stellantis' plan to put four European factories up for sale indicates the company is facing financial difficulties and signals operational contraction. This news could have an indirect negative impact on Ford's stock, as it confirms weakness in the automotive sector. Technically, the RSI is at 45.8, in neutral territory, while the MACD is below the signal line and negative, pointing to short-term weakness. The price being near the 20-day moving average increases the risk of encountering resistance. Therefore, a downward movement can be expected in the short term.

HMC shares are showing a weak technical outlook. The RSI is at 40, approaching the oversold zone, while the MACD is below the signal line and in negative territory. The price is trading below both the 20-day and 50-day moving averages. News indicates a contraction in demand in the automotive sector, which could also negatively impact HMC. Selling pressure is expected to persist in the short term.